| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
44,215,000 |
| Market
Cap: |
3.69(M) |
| Last
Volume: |
900 |
Avg
Vol: |
59,812 |
| 52
Week Range: |
$0.06 - $0.22 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
| |
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Enzon Pharmaceuticals is engaged in existing licensing arrangements with other companies primarily related to sales of certain drug products that utilize Co.'s proprietary technology. Co. has a marketing agreement relating to the drug Vicineum.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
99,550 |
99,550 |
| Total Buy Value |
$0 |
$0 |
$13,910 |
$13,910 |
| Total People Bought |
0 |
0 |
1 |
1 |
| Total Buy Transactions |
0 |
0 |
2 |
2 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Horak Ivan D |
EVP, R&D, CSO |
• – – |
2011-04-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
26,480 |
147,856 |
|
- |
|
| Delcampo Ralph |
COO and Princ. Exec. Officer |
• – – |
2011-04-03 |
4 |
D |
$11.02 |
$65,580 |
D/D |
(5,951) |
169,633 |
|
- |
|
| Delcampo Ralph |
COO and Princ. Exec. Officer |
• – – |
2011-04-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
16,800 |
175,584 |
|
- |
|
| Davit Paul Stephen |
Exec. Vice Pres. HR |
• – – |
2011-04-03 |
4 |
D |
$11.02 |
$41,512 |
D/D |
(3,767) |
111,283 |
|
- |
|
| Davit Paul Stephen |
Exec. Vice Pres. HR |
• – – |
2011-04-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
12,760 |
115,050 |
|
- |
|
| Delcampo Ralph |
COO and Princ. Exec. Officer |
• – – |
2011-03-30 |
4 |
D |
$10.76 |
$9,533 |
D/D |
(886) |
158,784 |
|
- |
|
| Delcampo Ralph |
COO and Princ. Exec. Officer |
• – – |
2011-03-30 |
4 |
A |
$0.00 |
$0 |
D/D |
2,500 |
159,670 |
|
- |
|
| Davit Paul Stephen |
Exec. Vice Pres. HR |
• – – |
2011-03-30 |
4 |
D |
$10.76 |
$4,239 |
D/D |
(394) |
102,290 |
|
- |
|
| Davit Paul Stephen |
Exec. Vice Pres. HR |
• – – |
2011-03-30 |
4 |
A |
$0.00 |
$0 |
D/D |
1,333 |
102,684 |
|
- |
|
| Horak Ivan D |
EVP, R&D, CSO |
• – – |
2011-03-30 |
4 |
D |
$10.76 |
$9,533 |
D/D |
(886) |
121,376 |
|
- |
|
| Horak Ivan D |
EVP, R&D, CSO |
• – – |
2011-03-30 |
4 |
A |
$0.00 |
$0 |
D/D |
2,500 |
122,262 |
|
- |
|
| Ogden Mark L |
Acting VP of Fin & Prin FO |
• – – |
2011-02-28 |
4 |
B |
$10.65 |
$21,298 |
D/D |
2,000 |
4,000 |
2.74 |
- |
|
| Lebuhn Robert |
Director |
– • – |
2011-02-22 |
4 |
S |
$10.88 |
$108,817 |
D/D |
(10,000) |
96,519 |
|
- |
|
| Icahn Carl C Et Al |
10% Owner |
– – • |
2011-02-17 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
5,904,863 |
|
- |
|
| Horak Ivan D |
EVP, R&D, CSO |
• – – |
2011-01-27 |
4 |
D |
$11.63 |
$70,594 |
D/D |
(6,070) |
122,262 |
|
- |
|
| Horak Ivan D |
EVP, R&D, CSO |
• – – |
2011-01-27 |
4 |
A |
$0.00 |
$0 |
D/D |
16,465 |
128,332 |
|
- |
|
| Davit Paul Stephen |
Exec. Vice Pres. HR |
• – – |
2011-01-27 |
4 |
D |
$11.63 |
$29,459 |
D/D |
(2,533) |
102,684 |
|
- |
|
| Davit Paul Stephen |
Exec. Vice Pres. HR |
• – – |
2011-01-27 |
4 |
A |
$0.00 |
$0 |
D/D |
7,599 |
105,217 |
|
- |
|
| Delcampo Ralph |
COO and Princ. Exec. Officer |
• – – |
2011-01-27 |
4 |
D |
$11.63 |
$55,173 |
D/D |
(4,744) |
159,670 |
|
- |
|
| Delcampo Ralph |
COO and Princ. Exec. Officer |
• – – |
2011-01-27 |
4 |
A |
$0.00 |
$0 |
D/D |
12,665 |
164,414 |
|
- |
|
| Horak Ivan D |
EVP, R&D, CSO |
• – – |
2011-01-17 |
4 |
D |
$12.15 |
$82,535 |
D/D |
(6,793) |
128,332 |
|
- |
|
| Horak Ivan D |
EVP, R&D, CSO |
• – – |
2011-01-17 |
4 |
A |
$0.00 |
$0 |
D/D |
18,333 |
135,125 |
|
- |
|
| Davit Paul Stephen |
Exec. Vice Pres. HR |
• – – |
2011-01-17 |
4 |
D |
$12.15 |
$13,657 |
D/D |
(1,124) |
105,217 |
|
- |
|
| Davit Paul Stephen |
Exec. Vice Pres. HR |
• – – |
2011-01-17 |
4 |
A |
$0.00 |
$0 |
D/D |
3,333 |
106,341 |
|
- |
|
| Delcampo Ralph |
COO and Princ. Exec. Officer |
• – – |
2011-01-17 |
4 |
D |
$12.15 |
$82,644 |
D/D |
(6,802) |
164,414 |
|
- |
|
394 Records found
|
|
Page 6 of 16 |
|
|
